Genetically-associated chronic obstructive pulmonary disease treatment
AssigneePneumRx, Inc.
InventorsMark L. Mathis, Kara Andersen Reiter
Life of this patent
Estimating the term…
Abstract
A method for treating a genetically associated chronic obstructive pulmonary disease. At least one implant is advanced into an airway of a lung having a genetically associated chronic obstructive pulmonary disease. The at least one implant is delivered into the lung to increase tension of the lung and thereby improve breathing function of the lung.
Claims15
A method for treating a genetically associated chronic obstructive pulmonary disease, comprising:
- advancing at least one implant into an airway of a lung of a patient having alpha-1 antitrypsin deficiency;
- and
- delivering the at least one implant into the lung to increase tension of the lung and thereby improve breathing function of the lung.
A method for treating a genetically associated chronic obstructive pulmonary disease, comprising:
- advancing at least one implant into an airway of a lung having uniformly distributed diseased alveolus within the lung;
- and
- compressing a portion of the uniformly distributed diseased alveolus using the at least one implant to cause improved breathing function of the lung.
A method for treating a genetically associated chronic obstructive pulmonary disease, comprising:
- implanting at least one implant into a lung having alveolar damage caused by alpha-1 antitrypsin deficiency to increase tension of the lung and thereby improve breathing function of the lung;
- and
- provide at least one augmentation therapy to boost circulating alpha-1 antitrypsin plasma levels within the lung and thereby slow or halt progression of the alveolar damage to the lung.
A method for treating a genetically associated chronic obstructive pulmonary disease, comprising:
- advancing at least one implant into an airway of a lung having intact and uniformly diseased alveolus within at least one lower lobe of the lung, the lung having non-diseased alveolus within upper lobes of the lung;
- and
- compressing the intact and uniformly diseased alveolus within the at least one lower lobe of the lung using the at least one implant to cause improved breathing function of the lung.
Dependencies are inferred from the claim text.